drugset / Trial / NCT01181141
Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery
RandomizedParallel-groupOpen-labelPrevention
Summary
The objective of this study is to evaluate the safety and efficacy of DU-176b compared with enoxaparin sodium for the prevention of venous thromboembolism in patients after elective hip fracture surgery.
Timeline
- Start
- 2008-10
- Primary completion
- 2009-08
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Edoxaban | Small molecule | 30 mg | Oral |
| Comparator | Enoxaparin sodium | Other / unclassified | 20 mg | Subcutaneous |